Amicus Therapeutics, Inc. (FOLD) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,71%	1 092,80	−7,77	−0,71%	—	1 100,57	1 098,94	1 103,80	1 084,24	—	—
SIXC Communications SIXC Communications	SIXC −0,07%	604,74	−0,41	−0,07%	—	605,15	605,15	606,69	602,76	—	—
SIXE Energy SIXE Energy	SIXE +1,64%	1 214,80	+19,61	+1,64%	—	1 195,19	1 204,71	1 221,69	1 204,71	—	—
SIXI Industrials SIXI Industrials	SIXI −0,88%	1 724,57	−15,34	−0,88%	—	1 739,91	1 734,50	1 734,50	1 710,67	—	—
SIXM Financials SIXM Financials	SIXM +0,14%	639,43	+0,87	+0,14%	—	638,56	640,21	645,32	638,69	—	—
SIXR Staples SIXR Staples	SIXR +0,91%	839,15	+7,58	+0,91%	—	831,57	840,48	844,16	834,54	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +1,06%	215,62	+2,26	+1,06%	—	213,36	213,36	215,79	212,77	—	—
SIXT Technology SIXT Technology	SIXT −1,69%	3 179,52	−54,66	−1,69%	—	3 234,18	3 171,86	3 195,36	3 145,46	—	—
SIXU Utilities SIXU Utilities	SIXU +0,13%	936,91	+1,26	+0,13%	—	935,65	937,31	941,44	933,16	—	—
SIXV Health care SIXV Health care	SIXV +0,24%	1 452,77	+3,51	+0,24%	—	1 449,26	1 454,77	1 462,65	1 447,95	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,72%	2 365,18	−17,27	−0,72%	—	2 382,45	2 371,19	2 380,45	2 362,86	—	—

FOLD:BMV

Amicus Therapeutics, Inc.

208,80 MXN

0,00%

(0,00) 1 D

26. sep., 08:51:06 GMT-6 · MXN

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for FOLD …

Markedsverdi

4,55 mrd.

Volum

0,00

52 u høy

208,80 MXN

52 u lav

208,80 MXN

Antall ansatte

511

Nyhetssaker

Fra kilder på nettet

Meyka

for 1 døgn siden

FOLD: Amicus Therapeutics Insiders Sell $31.5M in Stock April 28

Stock Titan

for 1 døgn siden

Director at Amicus (NASDAQ: FOLD) exits stake in BioMarin deal

Investing.com Canada

for 1 døgn siden

BioMarin completes $4.8B acquisition of Amicus Therapeutics By Investing.com

PR Newswire

for 1 døgn siden

BioMarin Completes Acquisition of Amicus Therapeutics

Profil

Amicus Therapeutics, Inc. is an American biopharmaceutical company based in Princeton, New Jersey. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. As of April 2026, Amicus Therapeutics is a subsidiary of BioMarin Pharmaceutical. Wikipedia

Om Amicus Therapeutics, Inc.

Administrerende direktørBradley L Campbell

Ansatte511

Grunnlagt4. feb. 2002

Hovedkontor-

Sektor-

Nettstedamicusrx.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	125,25 mill.	154,69 mill.	169,06 mill.	185,21 mill.
Varekostnad	11,70 mill.	15,22 mill.	19,47 mill.	26,55 mill.
Direkte driftskostnader	11,70 mill.	15,22 mill.	19,47 mill.	26,55 mill.
Utgifter til forskning og utvikling	27,84 mill.	60,85 mill.	23,42 mill.	23,74 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	91,83 mill.	84,54 mill.	90,04 mill.	117,08 mill.
Driftskostnader	121,50 mill.	147,24 mill.	115,32 mill.	142,72 mill.
Totale driftskostnader	133,20 mill.	162,46 mill.	134,79 mill.	169,27 mill.
Driftsinntekter	−7,95 mill.	−7,77 mill.	34,27 mill.	15,95 mill.
Andre ikke-operasjonelle inntekter	550,00k	1,02 mill.	10,89 mill.	−2,21 mill.
EBT inkludert uvanlige elementer	−18,04 mill.	−19,18 mill.	34,27 mill.	3,14 mill.
EBT uten uvanlige elementer	−18,04 mill.	−17,48 mill.	34,27 mill.	3,14 mill.
Kostnad for inntektsskatt	3,64 mill.	5,24 mill.	16,97 mill.	1,45 mill.
Faktisk avgiftssats	−20,18 %	−27,31 %	49,51 %	46,23 %
Andre driftskostnader	-	-	-	-
Nettoinntekt	−21,69 mill.	−24,42 mill.	17,31 mill.	1,69 mill.
Netto fortjenestemargin	−17,31 %	−15,79 %	10,24 %	0,91 %
Resultat per aksje	0,03	0,01	0,17	0,10
Rente- og investeringsinntekter	812,00k	843,00k	829,00k	833,00k
Rentekostnader	−11,46 mill.	−11,56 mill.	−11,71 mill.	−11,43 mill.
Netto rentekostnader	−10,64 mill.	−10,72 mill.	−10,88 mill.	−10,60 mill.
Avskrivnings- og amortiseringskostnader	1,84 mill.	1,85 mill.	1,87 mill.	1,90 mill.
EBITDA	−6,12 mill.	−5,92 mill.	36,14 mill.	17,84 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning